D07001-softgel capsules

DRUG2 trials

Sponsors

InnoPharmax Inc.

Conditions

Biliary Tract CancerBiliary Tract Cancer (BTC)Gastrointestinal Cancer

Phase 1

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

CompletedNCT03531320

InnoPharmax Inc.Biliary Tract Cancer, Gastrointestinal Cancer

Start: 2018-08-06End: 2020-12-29Updated: 2023-11-24

Phase 3

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

RecruitingNCT06622057

InnoPharmax Inc.Biliary Tract Cancer (BTC)

Start: 2026-06-09End: 2028-12-31Target: 240Updated: 2026-07-30

Related Papers

Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors.

Journal of Clinical Oncology2023-06-01